These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19124547)

  • 21. Postoperative levels of cardiac troponin versus CK-MB and high-sensitivity C-reactive protein for the prediction of 1-year cardiovascular outcome in patients undergoing vascular surgery.
    Kouvelos GN; Milionis HJ; Arnaoutoglou EM; Chasiotis G; Gartzonika C; Papa NK; Tzimas P; Matsagkas MI
    Coron Artery Dis; 2011; 22(6):428-34. PubMed ID: 21730823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Troponin I and cardiovascular events in transplant patients.
    Afsar B; Elsure R
    Transplantation; 2010 Aug; 90(3):339; author reply 339-40. PubMed ID: 20683433
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiovascular screening.
    Kelly HB
    Practitioner; 1981 May; 225(1355):625-30. PubMed ID: 7291116
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical inquiries. What is the best management for patients with evidence of asymptomatic ischemia on exercise stress testing?
    Raymond LW; Kaufman L; Healy RL
    J Fam Pract; 2007 Jan; 56(1):53-5. PubMed ID: 17217900
    [No Abstract]   [Full Text] [Related]  

  • 25. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease.
    Guijarro C
    Circulation; 2001 Nov; 104(22):E127. PubMed ID: 11723039
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhanced risk assessment in asymptomatic individuals with exercise testing and Framingham risk scores.
    Mora S; Redberg RF; Sharrett AR; Blumenthal RS
    Circulation; 2005 Sep; 112(11):1566-72. PubMed ID: 16144993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease? Or are we putting the cart before the horse?
    Wong ND
    Prev Cardiol; 2010; 13(4):149-51. PubMed ID: 20860636
    [No Abstract]   [Full Text] [Related]  

  • 28. Determinants of coronary artery disease in liver transplant candidates.
    Aydinalp A; Atar I; Bal U; Aktas A; Ertan C; Atar A; Yildirir A; Ozin B; Muderrisoglu H; Haberal M
    Exp Clin Transplant; 2010 Jun; 8(2):142-5. PubMed ID: 20565371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ST elevation in the lead aVR during exercise treadmill testing may indicate left main coronary artery disease.
    Ozmen N; Yiginer O; Uz O; Kardesoglu E; Aparci M; Isilak Z; Cingozbay BY; Cebeci BS; Kocum HT
    Kardiol Pol; 2010 Oct; 68(10):1107-11. PubMed ID: 20967704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. C-reactive protein in cardiovascular risk prediction. Zooming in and zooming out.
    Maseri A
    Ital Heart J; 2001 Mar; 2(3):155-6. PubMed ID: 11305525
    [No Abstract]   [Full Text] [Related]  

  • 32. After menopause: novel marker helps to identify women at risk for heart disease.
    Lewis SL
    J Fam Pract; 2004 Jul; Suppl():S18-24. PubMed ID: 15251109
    [No Abstract]   [Full Text] [Related]  

  • 33. Exercise tolerance testing after myocardial infarction.
    Quinney K
    Nurs Times; 2005 Sep 6-12; 101(36):28-30. PubMed ID: 16163931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An imaging approach to high-risk screening for breast cancer.
    Jochelson MS; Morris EA
    Semin Roentgenol; 2011 Jan; 46(1):68-75. PubMed ID: 21134530
    [No Abstract]   [Full Text] [Related]  

  • 35. Exercise testing: screening and reproducibility in asymptomatic subjects.
    Faris JV
    Cardiol Clin; 1984 Aug; 2(3):415-28. PubMed ID: 6399871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-cost strategies to predict cardiovascular disease.
    Wilson PW; Narayan KM
    Nat Clin Pract Cardiovasc Med; 2008 Sep; 5(9):518-9. PubMed ID: 18628774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular screening in asymptomatic adults: lessons for the diving world.
    Douglas PS
    Undersea Hyperb Med; 2011; 38(4):279-87. PubMed ID: 21877557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Basic diagnosis of cardiovascular diseases--value of the combined use of a standardized anamnesis and blood pressure measurement].
    Bohm R; Günther KH; Petzschmann S; Läuter J
    Z Arztl Fortbild (Jena); 1987; 81(19):1003-5. PubMed ID: 3439212
    [No Abstract]   [Full Text] [Related]  

  • 39. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
    Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
    Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.